Alpine Woods Capital Investors’s Neuronetics STIM Stock Holding History

Alpine Woods Capital Investors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-26,000	Closed	-$397K	–	287
2019 Q1	$397K	Hold	26,000	–	–	0.09%	194
2018 Q4	$503K	Buy	26,000 +12,000	+86%	+$263K	0.12%	167
2018 Q3	$449K	Buy	14,000 +4,000	+40%	+$122K	0.09%	165
2018 Q2	$266K	Buy	+10,000	New	+$272K	0.06%	201

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alpine Woods Capital Investors's STIM Position: Q2 2019 in Review

Alpine Woods Capital Investors sold out of Neuronetics (STIM) in Q2 2019, closing a stake of 26,000 shares — an estimated $397K sold.

Alpine Woods Capital Investors first reported a position in STIM in Q2 2018 and held it in 4 quarters. The position peaked at $503K in Q4 2018. 59 funds tracked by Wall St. Rank hold STIM as of Q2 2019.

Alpine Woods Capital Investors reported no remaining Neuronetics position as of Q2 2019 after selling out during the quarter.
Alpine Woods Capital Investors sold 26,000 Neuronetics shares in Q2 2019, an estimated $397K.
Alpine Woods Capital Investors first reported a position in Neuronetics in Q2 2018 and held it in 4 quarters.
Alpine Woods Capital Investors's Neuronetics position peaked at $503K in Q4 2018.
59 funds tracked by Wall St. Rank held Neuronetics as of Q2 2019.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2019, filed 5 Aug 2019.